Prescriber Briefing Resources
Unfortunately, there are still physicians out there who question the legitimacy of pharmacy compounding, so they’re reluctant to consider the compounded therapies you can provide their patients. (Or worse, they ask you to compound substances that are prohibited.)
To help you educate your prescribers, APC and the Pharmacy Compounding Foundation have developed five member-only briefing documents you can share with physicians and other medical professionals:
- The Truth About Pharmacy Compounding, which explains the regulatory framework under which compounders operate and provides an overview of what can and cannot be compounded under federal law.
- Compounding Peptides: It’s Complicated. This briefing explains restrictions on peptide compounding as well as uncertainty surrounding the list of semaglutide on FDA’s Drug Shortage List. An updated briefing will be available soon.
- Prescription Compliance: DEA’s “Wet Signature” Requirement. This briefing explains how the Drug Enforcement Agency’s (DEA) “wet signature” requirement applies to electronic prescriptions for controlled substances.
- Documenting Medical Rationale. With enforcement of FDA’s GFI 256 set to commence April 1, 2023, APC has developed this briefing to help you coach the veterinarians you work with on what they must document on prescriptions for compounded animal drugs.
- Compounding for Racehorses: An Overview for Veterinarians. As a tightly regulated sport, horseracing has specific rules and regulations regarding the use of drugs in horses, including the use of compounded ones.
The APC and PCF logos give credibility to the documents, and both are designed so you can add your pharmacy logo as well.
You can find all of the briefings here and share them with the physician offices you or your sales reps visit. (Note: It’s an APC member-only tool, so you’ll need your login and password to access it.)
